Metabolism of A-ring diastereomers of 1α,25-dihydroxyvitamin D 3 by CYP24A1

Biochemical and Biophysical Research Communications

Volumn 321, Issue 4, 2004, Pages 774-782

  Kusudo, Tatsuya ^a   Sakaki, Toshiyuki ^a,b   Abe, Daisuke ^a   Fujishima, Toshie ^c   Kittaka, Atsushi ^c   Takayama, Hiroaki ^c   Hatakeyama, Susumi ^d   Ohta, Miho ^e   Inouye, Kuniyo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e 4 25 Kawarabayashi cho N   (Japan)

Author keywords

CYP24; Cytochrome P450; Diastereomers of vitamin D; Metabolism of vitamin D; Species based difference; Vitamin D analog

Indexed keywords

1BETA,25 DIHYDROXYCOLECALCIFEROL; CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 CYP24A1; DRUG METABOLITE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIASTEREOISOMER; DRUG METABOLISM; ENZYME SPECIFICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

ANIMALS; CALCITRIOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROXYLATION; ISOMERISM; KINETICS; MASS SPECTROMETRY; OXIDATION-REDUCTION; RATS; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; STEREOISOMERISM; STEROID HYDROXYLASES; SUBSTRATE SPECIFICITY;

EID: 3843067665     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.040     Document Type: Article

References (36)

1. R. Bouillon, W.H. Okamura, and A.W. Norman Structure-function relationships in the vitamin D endocrine system Endocr. Rev. 16 1995 200 257
2. 3 and its analogs J. Bone Miner. Res. 9 1994 1277 1288
3. S. Yamada, M. Shimizu, and K. Yamamoto Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor Med. Res. Rev. 23 2003 89 115
4. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia Endocrinology 129 1991 832 837
5. 3 derivative, on calcium metabolism Biochem. Biophys. Res. Commun. 163 1989 1444 1449
6. 3 selectively induces bone formation Proc. Natl. Acad. Sci. USA 99 2002 13487 13491
7. 3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues J. Med. Chem. 41 1998 4662 4674
8. 3 Steroids 66 2001 277 285
9. 3: transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells Biochem. Pharmacol. 59 2001 691 702
10. 3 and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20 J. Med. Chem. 43 2000 4247 4265
11. 3 analogues: a novel class of potent regulators of cell growth and immune responses Biochem. Pharmacol. 42 1991 1569 1575
12. L. Binderup Immunological properties of vitamin D analogues and metabolites Biochem. Pharmacol. 43 1992 1885 1892
13. F.J. Dilorth, G.R. Williams, A.M. Kissmeyer, J.L. Nielsen, E. Binderup, M.J. Calverley, H.L. Makin, and G. Jones The vitamin D analog KH1060, is rapidly degraded both in vivo and in vitro via several pathways: Principal metabolites generated retain significant biological activity Endocrinology 138 1997 5485 5496
14. 3-24-hydroxylase, a multicatalytic enzyme Biochemistry 35 1996 8465 8472
15. 3 catalyzed by human CYP24 Eur. J. Biochem. 267 2000 6158 6165
16. T. Sakaki, N. Sawada, Y. Nonaka, Y. Ohyama, and K. Inouye Metabolic studies using recombinant Escherichia coli cells producing rat mitochondrial CYP24 Eur. J. Biochem. 262 1999 43 48
17. 3-23-hydroxylase, a renal enzyme in several animal species Arch. Biochem. Biophys. 250 1986 86 93
18. 3 by CYP24: species-based difference between humans and rats Biochem. Pharmacol. 65 2003 1957 1965
19. 3 by CYP24: species-based difference between humans and rats Biochem. Biophys. Res. Commun. 309 2003 885 892
20. 3 and its 20-epimer Bioorg. Med. Chem. 8 2000 123 134
21. 25 bond cleavage catalyzed by human CYP24A1 Biochemistry 43 2004 4530 4537
22. 2 J. Org. Chem. 51 1986 1264 1269
23. M. Akiyoshi-Shibata, T. Sakaki, Y. Ohyama, M. Noshiro, K. Okuda, and Y. Yabusaki Further oxidation of hydroxycalcidiol by calcidiol 24-hydroxylase Eur. J. Biochem. 224 1994 335 343
24. T. Omura, and T.R. Sato The carbon monoxide-binding pigment of liver microsomes, II. Solubilization, purification, and properties J. Biol. Chem. 239 1964 2379 2385
25. 3-1α-hydroxylase) of bovine kidney mitochondria Biochem. Biophys. Res. Commun. 105 1982 320 327
26. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J. Biol. Chem. 193 1951 265 275
27. 3 metabolite with high affinity for the 1,25-dihydroxyvitamin D specific cytosol receptor Biochemistry 22 1983 245 250
28. J.L. Napoli, N.J. Koszewski, and R.L. Horst Isolation and identification of vitamin D metabolites Methods Enzymol. 123 1986 127 140
29. 3 by human CYP27A1 Biochem. Biophys. Res. Commun. 273 2000 977 984
30. K. Takeyama, Y. Masuhiro, H. Fuse, H. Endoh, A. Murayama, S. Kitanaka, M. Suzawa, J. Yanagisawa, and S. Kato Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog Mol. Cell. Biol. 19 1999 1049 1055
31. 3 receptor J. Biol. Chem. 274 1999 16838 16845
32. 3H-ST-630 in rats Xenobio. Metabol. Dispos. 11 1996 505 517
33. N. Rochel, J.M. Wurtz, A. Mitschler, B. Klaholz, and D. Moras The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand Mol. Cell 5 2000 173 179
34. 3 in rats FEBS Lett. 1999 278 282
35. P.A. Williams, J. Cosme, V. Sridhar, E.F. Johnson, and D.E. McRee Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity Mol. Cell 5 2000 121 131
36. P.A. Williams, J. Cosme, A. Ward, H.C. Angove, V.D. Matak, and H. Jhoti Crystal structure of human cytochrome P450 2C9 with bound warfarin Nature 424 2003 464 468